Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma
NCT00846456
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Brain Tumor
Interventions
BIOLOGICAL:
Dendritic cell vaccine with mRNA from tumor stem cells
Sponsor
Oslo University Hospital